Carbocyclodipeptides as modified nucleosides: synthesis and anti-HIV activities

被引：1

作者：

Chhikara, Bhupender S. ^{[1
]}

Rao, M. Sudershan ^{[2
]}

Rao, V. Kameshwara ^{[2
]}

Kumar, Anil ^{[2
]}

Buckheit, Karen W. ^{[3
]}

Buckheit, Robert W., Jr. ^{[3
]}

Parang, Keykavous ^{[1
,2
,4
]}

机构：

[1] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Coll Pharm, Kingston, RI 02881 USA

[2] Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India

[3] ImQuest BioSci Inc, Frederick, MD 21704 USA

[4] Chapman Univ, Sch Pharm, Irvine, CA 92618 USA

来源：

CANADIAN JOURNAL OF CHEMISTRY | 2014年 / 92卷 / 12期

基金：

美国国家卫生研究院;

关键词：

anti-HIV; carbopeptides; cyclodipeptide; nucleoside analogues; 2 '-deoxyribofuranosyl; CELLULAR UPTAKE; ANALOGS; PRODRUGS; CYCLODIPEPTIDES; DERIVATIVES; INHIBITION;

D O I：

10.1139/cjc-2014-0356

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A new class of nucleoside analogues were synthesized using cyclic dipeptides and modified 2'-deoxyfuranoribose sugars to introduce flexibility by peptides in place of common nucleoside bases and to determine their biological properties. The synthesis was carried out by coupling of a protected ribose sugar with synthesized dipeptides in the presence of hexamethyldisilazane and trimethylsilyltriflate. The final products were characterized by NMR and high-resolution MS-TOF spectroscopy. The compounds were evaluated for anti-HIV activities. 1-(4-Azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,6-diisopropylpiperazine2,5-dione (compound 14) containing 3- and 6-isopropyl groups in the base and 3'-azide (EC50 = 1.96 mu mol/L) was the most potent compound among all of the synthesized analogs.

引用

页码：1145 / 1149

页数：5

共 50 条

[41] Synthesis of anti-HIV lithospermic acid by two diverse strategies
Varadaraju, Tirumala G.
Hwu, Jih Ru
ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (28) : 5456 - 5465
[42] Pyrazole Containing Anti-HIV Agents: An Update
Kumar, Sanjay
Gupta, Shiv
Rani, Varsha
Sharma, Priyanka
MEDICINAL CHEMISTRY, 2022, 18 (08) : 831 - 846
[43] Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives
Bal, TR
Anand, B
Yogeeswari, P
Sriram, D
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4451 - 4455
[44] Design, synthesis and anti-HIV activity of novel quinoxaline derivatives
Patel, Saloni B.
Patel, Bhumika D.
Pannecouque, Christophe
Bhatt, Hardik G.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 117 : 230 - 240
[45] PHARMACOLOGY AND SYNTHESIS OF DAURICHROMENIC ACID AS A POTENT ANTI-HIV AGENT
Bukhari, Syed Majid
Ali, Iftikhar
Zaidi, Asma
Iqbal, Naseem
Noor, Tayyaba
Mehmood, Rashad
Chishti, Muhammad Salman
Niaz, Basit
Rashid, Umer
Atif, Muhammad
ACTA POLONIAE PHARMACEUTICA, 2015, 72 (06): : 1059 - 1071
[46] 5′-Phosphonate Derivatives of 2′,3′-Dideoxy-3′-Thiacytidine as New Anti-HIV Prodrugs
Khandazhinskaya, Anastasia L.
Jasko, Maxim V.
Karpenko, Inna L.
Solyev, Pavel N.
Golubeva, Natalia A.
Kukhanova, Marina K.
CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (01) : 50 - 56
[47] Anti-HIV and NO production inhibition activities of epi-aleuritolic acid derivatives
Liu, Jia-Bao
Zhang, Ying
Cui, Bao-Song
Cao, Ying-Li
Yuan, Shao-Peng
Guo, Ying
Hou, Qi
Li, Shuai
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2013, 15 (05) : 515 - 524
[48] Synthesis and Anti-HIV Activities of Suramin Conjugates of 3′-Fluoro-2′,3′-dideoxythymidine and 3′-Azido-2′,3′-dideoxythymidine
Agarwal, Hitesh K.
Doncel, Gustavo F.
Parang, Keykavous
MEDICINAL CHEMISTRY, 2012, 8 (02) : 193 - 197
[49] Platinum(II) and Ruthenium(II) complexes in medicine: Antimycobacterial and Anti-HIV activities
Yufanyi, Divine Mbom
Abbo, Hanna S.
Titinchi, Salam J. J.
Neville, Tambua
COORDINATION CHEMISTRY REVIEWS, 2020, 414
[50] Boromycin, an anti-HIV antibiotic
Kohno, J
Kawahata, T
Otake, T
Morimoto, M
Mori, H
Ueba, N
Nishio, M
Kinumaki, A
Komatsubara, S
Kawashima, K
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1996, 60 (06) : 1036 - 1037

← 1 2 3 4 5 →